Facing pressure from healthcare professionals, voters and media, lawmakers are struggling to address the opioid crisis which claims 91 lives in the U.S. every single day. Despite their efforts in drafting legislation, proposing initiatives, formulating strategies and coming up with lofty proposals, well-meaning lawmakers are missing a key solution to mitigating the opioid crisis: Making a less-addictive opioid—buprenorphine (CIII)—more widely available by expanding insurance coverage for it.